Work

Efficacy following discontinuation of sonidegib 200 mg daily treatment in patients with locally advanced basal cell carcinoma: Post hoc analysis of the 42-month BOLT study

Year: 2025

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2025.04.030

Authors: Michael R. Migden, Meenal Kheterpal, Brent Moody, Kunal Patel, Leonard Lionnet, Sakthivel Sivam, Joe Conti, Nicholas Squittieri, Aaron S. Farberg

Institutions: The University of Texas MD Anderson Cancer Center, Duke University, New York Medical College

Language: English

Topic: Nonmelanoma Skin Cancer Studies

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,200

Funders: Novartis, Novartis Pharmaceuticals Corporation, Sun Pharma

OpenAlex ID: W4409450710

FWCI:

Cites: 3

Cited by:

Related to: 10